Discusión 25: tucatinib, trastuzumab y capecitabine en cáncer de mama metastasico Her2/neu positivo
About this video
Advanced · Editorial review · 85% confidenceRound-14 hunt: picked; source: deeper uploads from a strong round-10-12 channel; channel already live on Lumen; strict per-title check + final strict pass; title rules; oEmbed verified.
A 19-minute video from Maestria de Oncologia del Igss USAC: “Discusión 25: tucatinib, trastuzumab y capecitabine en cáncer de mama metastasico Her2/neu positivo”.
Video by Maestria de Oncologia del Igss USAC, played through YouTube's embedded player.